Medtide Inc. Reports 28.5% Rise in Revenue and 101.7% Increase in Net Profit for H1 2025
I'm PortAI, I can summarize articles.
Medtide Inc. reported a 28.5% increase in revenue for H1 2025, reaching RMB 253.8 million, and a 101.7% rise in net profit to RMB 102.0 million. The gross profit margin improved to 61.1%. The company completed its global offering and became listed in June 2025, funding operations through business activities and equity issuance. Medtide aims for sustainable growth in CRDMO services for peptides and oligonucleotides while managing liquidity for shareholder stability and returns.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments